- Clinical Trials
- April 2025
- 40 Pages
Global
From €1138EUR$1,250USD£966GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1138EUR$1,250USD£966GBP
- Report
- December 2024
- 30 Pages
Global
From €2958EUR$3,250USD£2,512GBP
- Report
- August 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,865GBP
- Report
- August 2024
- 150 Pages
Global
From €2538EUR$2,789USD£2,156GBP
- Report
- October 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,899GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more